Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada

BACKGROUND: Depot formulations of antipsychotics provide a potential solution to the poor adherence to oral therapies in schizophrenia. However, there have been few comparative studies on the effectiveness and tolerability of first and second generation depot antipsychotics in a real clinical practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lammers, Laura, Zehm, Bree, Williams, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669627/
https://www.ncbi.nlm.nih.gov/pubmed/23718192
http://dx.doi.org/10.1186/1471-244X-13-155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669627/
https://www.ncbi.nlm.nih.gov/pubmed/23718192
http://dx.doi.org/10.1186/1471-244X-13-155

Ejemplares similares